In lung cancer, Nrp2 expression is correlated with advanced disease stage at diagnosis, epithelial-to-mesenchymal transition (EMT), metastasis, decreased survival, and drug resistance [88,89,90,91,92]. The gene discussed is NRP2; the disease is lung carcinoma.